MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Tranylcypromine hydrochloride

CAS No. : 1986-47-6

MCE 国际站：Tranylcypromine hydrochloride

产品活性：Tranylcypromine hydrochloride (SKF 385 hydrochloride) 是 lysine-specific demethylase 1 (LSD1/BHC110) 和 monoamine oxidase (MAO) 的不可逆抑制剂。Tranylcypromine hydrochloride 抑制 LSD1，MAO A 和 MAO B 的 IC₅₀ 值分别为 20.7，2.3 和 0.95 μM。Tranylcypromine hydrochloride 可用于忧郁症的研究。

研究领域：Neuronal Signaling

作用靶点：Monoamine Oxidase

In Vitro: Tranylcypromine hydrochlorid (50 μM-5 mM; 1 h or 12-14 h) inhibits histone and nucleosomal demethylation.
Tranylcypromine hydrochlorid (2 μM; 3 h) shows a specific derepression of OCT4 transcription.
Tranylcypromine hydrochlorid (0-100 μM; 15 min) shows IC₅₀ values of 20.7, 2.3 and 0.95 μM for LSD1, MAO A and MAO B, respectively.
Tranylcypromine hydrochlorid (0-800 μM) shows K_i values of 242.7, 101.9 and 16 μM for LSD1, MAO A and MAO B, respectively.

In Vivo: Tranylcypromine hydrochlorid (3 mg/kg; i.p. once daily for 3 days) decreases LPS-mediated microglial activation and proinflammatory cytokine COX-2 and IL-6 levels in wild-type mice.
Tranylcypromine hydrochlorid (3 mg/kg; i.p. once daily for 7 days) down-regulates Aβ-mediate microglial activation in 5xFAD mice.

相关产品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Neuronal Signaling Compound Library  |  FDA-Approved Drug Library  |  Fragment Library  |  Drug Repurposing Compound Library  |  Reprogramming Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  Anti-Parkinson's Disease Compound Library  |  Neurodegenerative Disease-related Compound Library  |  Mitochondria-Targeted Compound Library  |  Antidepressant Compound Library  |  Off-patent Drug Library  |  Highly Selective Inhibitors Library  |  Moclobemide N-Oxide  |  MAO-B-IN-9  |  Hypericin  |  Lenumlostat  |  Homopterocarpin  |  MAO-B-IN-13  |  (1S,2R)-Tranylcypromine hydrochloride  |  PXS-4681A  |  Safinamide mesylate  |  Phenelzine sulfate  |  Amitraz  |  Contezolid acefosamil sodium  |  hMAO-B-IN-2  |  1,4-Naphthoquinone-d₆  |  Pivalylbenzhydrazine  |  Monoamine oxidase  |  MAO-A/B-IN-2  |  MAO A/HDAC-IN-1  |  MAO-B-IN-21  |  AChE/MAO-IN-2  |  Salsolidine hydrochloride  |  MAO-B-IN-1  |  Harmane-d  |  MAO-B-IN-17  |  MAO-A/5-HT2AR-IN-1  |  Tranylcypromine hemisulfate  |  MAO-B-IN-5  |  Pheniprazine hydrochloride  |  Lazabemide  |  Eckol

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物  |  寡核苷酸  |  抗体  |  点击化学

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

货号: HY-17447A

品牌介绍:
•   MCE (MedChemExpress) 拥有200 多种全球独家化合物库，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
•   50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领；
•   产品种类涵盖各种重组蛋白，多肽，常用试剂盒 ，更有 PROTAC、ADC 等特色产品，广泛应用于新药研发、生命科学等科研项目；
•   提供虚拟筛选，离子通道筛选，代谢组学分析检测分析，药物筛选等专业技术服务；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
•   专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。